News

Gilead Sciences shows strong Q1 execution, pipeline momentum, and margin upside, led by HIV and PrEP launches. See why GILD ...
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Goldman Sachs analyst ...
Gilead Sciences Inc. (NASDAQ:GILD) is one of the 11 most profitable NASDAQ stocks to buy now. On June 11, RBC Capital ...
FARMERS across Region Six (East Berbice-Corentyne) are voicing their strong support for the Ministry of Agriculture, commending the ministry for its continued ...
The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.
Gilead Sciences Inc. closed 8.32% below its 52-week high of $119.96, which the company reached on March 10th.
Bowling Green police were dispatched to the 1000 block of Fairview Avenue on Tuesday for a report of people refusing to leave ...
Let’s just say you wake up one morning in The Handmaid’s Tale universe, stuck inside the color-coded hellscape that is Gilead ...
Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...
Now that The Handmaid’s Tale has revealed its ending, a new tale is coming into focus: sequel series The Testaments.
The actor who plays Moira on the recently concluded Emmy-winning Hulu series reflects on what she calls a remarkable yet heavy run in the dystopian world.
Decreasing CD4 and lymphocyte counts in some participants receiving an oral combination therapy led to holds in the study.